Skip to main
  1. Stocks
  2. NRC Health
  3. Forecast
NRC

NRC Health (NRC) Stock Forecast & Price Target

NRC Health (NRC) Analyst Ratings

Based on 1 analyst ratings
Buy
Strong Buy 0%
Buy 100%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

NRC Health is supported by a differentiated healthcare-specific experience management platform, a 45-year operating history, and proprietary data that serves more than 250 of the country’s 400 largest health systems, giving it durable relevance in consumerism, transparency, and value-based care. Its 3Q26 results reinforced that setup, with revenue of $38.4M beating estimates by 7%, EBITDA of $10.9M above plan, and TRCV rising to $154M, while the large customer go-live and multi-year renewals point to stronger forward visibility. Management’s renewed focus on growth and retention, along with sequential margin improvement expected in 4Q and a path toward higher profitability, underpins a constructive view despite debt of $103M and shareholder capital returns.

Bears say

NRC Health is facing a weak fundamental setup because industry consolidation may prolong sales cycles, while efforts to reaccelerate Insights and TGI growth may fall short and make its expense assumptions too optimistic. Profitability also looks pressured, with SG&A at about 40% of revenue in 2025, or 31% excluding one-time and non-cash items, while recent growth appears concentrated in the top 10 customers, masking revenue compression from the rest of the base. The balance sheet and trading profile add risk, as management may fund dividends and buybacks with more capital than it generates, leverage could rise, and the 12M-share float with under 125K to 150K average daily volume suggests thin liquidity.

NRC Health (NRC) has been analyzed by 1 analysts, with a consensus rating of Buy. 0% of analysts recommend a Strong Buy, 100% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of NRC Health and is not a guaranteed prediction by Public.com or investment advice.

NRC Health (NRC) Analyst Forecast & Price Prediction

Get the latest NRC Health (NRC) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in NRC Health (NRC)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About NRC Health (NRC) Forecast

Analysts have given NRC Health (NRC) a Buy based on their latest research and market trends.

According to 1 analysts, NRC Health (NRC) has a Buy consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $27, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $27, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

NRC Health (NRC)


NRC Health (NRC) Analyst Forecast & Price Prediction

Get the latest NRC Health (NRC) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in NRC Health (NRC)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover NRC stock data and trends